AzTrials
AzTrials

Grade I and II Knee Meniscal InjuriesNCT06798428

For Grade I and II Knee Meniscal Injuries Patients ,Glucosamine, Chondroitin and Some Herbs Extract Phonophoresis Will Be Used (A) Versus Placebo(B)

A study testing group A will receive ultrasound phonophoresis (Glucosamine, Chondroitin and Some Herbs Extract ) and Group B will receive ultrasound with topical gel , same parameter as group A in people with Grade I and II Knee Meniscal Injuries, run by Eslam Elsayed Ali Shohda at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hypothesis: In grade I and II meniscal injury patients, 1) GL and CH (PH) decrease knee pain severity measured by Numerical Rating Scales (NRS) more than only topical application. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Grade I and II Knee Meniscal Injuries
What is being tested?
group A will receive ultrasound phonophoresis (Glucosamine, Chondroitin and Some Herbs Extract ) and Group B will receive ultrasound with topical gel , same parameter as group A
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
45 participants
Where
1 siteEgypt
Study dates
1 Oct 2022to 1 Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • grade I or II knee meniscal tear assessed by MRI according to radiologist report, positive McMurray's test assessed by physical therapist and aged from 18 to 60 years.

Who cannot join

  • We suggest not to include grade III meniscal injury as it is supposed that they need more physical therapy sessions. Ages above 40 is excluded to exclude arthritic changes. Presence of any other knee injury or systemic diseases affecting joints (e.g. rheumatoid arthritis) will be excluded. Patients with body mass index (BMI) more than 30 will be excluded as their knees may have some arthritic changes and need longer PT sessions.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Al ahrar teaching hospital

    Zagazig, Sharqia Province, 44511

Other trials in Egypt

About this study

Official title: Effect of Glucosamine, Chondroitin and Some Herbs Extract Phonophoresis in the Treatment of Grade I and II Knee Meniscal Injuries: a Randomized Placebo-controlled Clinical Trial.

Hypothesis: In grade I and II meniscal injury patients, 1) GL and CH (PH) decrease knee pain severity measured by Numerical Rating Scales (NRS) more than only topical application. 2) GL and CH (PH) improve knee functional abilities measured by Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) more than only topical application.

Read the detailed description

Design and Setting: We propose a randomized (1:1:1) controlled, clinical trial to enroll grade I and II knee meniscal injuries' patients and to study the effect of GL, CH and some natural herbs (PH) in decreasing knee pain intensity measured by NRS and improving knee functional abilities measured by WOMAC. The study will be conducted in physical therapy outpatient clinic at Alahrar teaching hospital, Zagazig, Egypt.

Inclusion and Exclusion criteria: patients will be included to this study

  • if they have grade I or II knee meniscal tear assessed by MRI according to radiologist report
  • positive McMurray's test assessed by physical therapist
  • aged from 18 to 40 years.

Exclusion criteria:

  • grade III meniscal injury as it is supposed that they need more physical therapy sessions.
  • Ages above 40 is excluded to exclude arthritic changes.
  • Presence of any other knee injury or systemic diseases affecting joints (e.g. rheumatoid arthritis) will be excluded.
  • Patients with body mass index (BMI) more than 30 will be excluded as their knees may have some arthritic changes and need longer PT sessions.

Sample size calculation: By reviewing literature, it is found that the most relevant study (5) to this work found that the mean pain score for treatment group is 5.25 ± 1.90 and for control group is 6.67 ± 1.78 so, by using G power (3.1) to calculate sample size (power = 0.8, alpha error = 0.05 and beta= 0.2) it is found that we need 15 patients for every group (45 patients for 3 groups). It is suggested that this would take about 1 year to complete the study.

Procedures: Patients will be evaluated by same physical therapist (researcher) to check his/her eligibility to be included to the study. Randomized blocks will be used to insure 1:1:1 blocked randomization. Pain severity will be evaluated by using NRS. Patients will be asked to indicate his/her knee pain severity (while usual movement) on the scale (zero is minimum and 10 is maximum). Knee functional abilities will be measured by (WOMAC) questioner which assess knee through 3 main items: pain, stiffness and physical function. Age, weight and height will be recorded. Every patient will be assessed at the beginning of the study and after last sessions by 2 days. Group (A)will have GL, CH and natural herbs (PH); the patient will be at supine lying position with a small bellow under his knee, a 4 cm gel (GL and CH 5%) will be used while US insonation under the head of US. Duration of US application is 10 min.US parameters are 1 W/cm for intensity, 1 MHz for frequency and 5 min continuous mode then 5 min pulsed mode. The device that will be used is medserve, England (the head of the device is 5cm). Group (B) will have US insonation with the same parameters as group (A), but with US topical gel (no drug). Group (c) will have topical gel applied with the head of US (10 min) while the machine is switched off (applied as massage). All patients will be referred to PT outpatient clinic by the orthopedist that standardize the drug protocol (anti-inflammatory drug) for all refereed patients. The physical therapy will by 6 successive sessions weekly for 2 weeks (12 sessions). PT sessions will be done by the same physical therapist.

Ethical aspects:

All patients will have a good explanation of their disease and available treatment. All patients will be instructed about the study and they have the choice to participate or not. In all cases patients will have their treatment.

Analysis of results:

Age, weight, height and BMI are expressed by mean (M) and standard deviation(SD). ANOVA test will be used to test if there is significant difference between groups regarding these variables. Investigators will compare between the three groups regarding pain severity measured by NRS (ordinal variables) and functional abilities measured by WOMAC which are expressed as median and inter quartile range (M) (IQR) by using Kruskal-Wallis test. Investigators will use logistic regression to compare between groups regarding frequency of triggering. Differences will be considered significant at P <0.05. Confidence interval will be calculated at 95%. Regression analysis will be used to investigate possible confounders (Age, weight, height, BMI and sex) especially if there is significant difference between the two groups regarding age, BMI and sex.

Being tested
group A will receive ultrasound phonophoresis (Glucosamine, Chondroitin and Some Herbs Extract ), Group B will receive ultrasound with topical gel , same parameter as group A, Group C sham ultrasound for massage - 5 minutes
Medical subject headings
Lymphoma, Follicular

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • group A will receive ultrasound phonophoresis (Glucosamine, Chondroitin and Some Herbs Extract )Device

    Group (A)will have GL, CH and natural herbs phonophoresis .Ultrasound parameters are 1 W/cm for intensity, 1 MHz for frequency and 5 min continuous mode then 5 min pulsed mode. The device that will be used is medserve, England (the head of the device is 5cm).

  • Group B will receive ultrasound with topical gel , same parameter as group ADevice

    Ultrasound parameters are 1 W/cm for intensity, 1 MHz for frequency and 5 min continuous mode then 5 min pulsed mode. The device that will be used is medserve, England (the head of the device is 5cm). Topical gel with no drugs

  • Group C sham ultrasound for massage - 5 minutesDevice

    sham ultrasound for massage - 5 minutes

Study groups in NCT06798428
Study groupRoleWhat they receive
expermental ( A)Experimentalgroup A, will receive ultrasound phonophoresis (Glucosamine, Chondroitin and Some Herbs Extract ) Ultrasound parameters are 1 W/cm for intensity, 1 MHz for frequency and 5 min continuous mode then 5 min pulsed mode
Receives: Device: group A will receive ultrasound phonophoresis (Glucosamine, Chondroitin and Some Herbs Extract )
BExperimentalgroup B, will receive ultrasound with topical gel , same parameter as group A
Receives: Device: Group B will receive ultrasound with topical gel , same parameter as group A
CSham comparatorgroup C, will receive ultrasound( machine is off) massage for 5 minutes
Receives: Device: Group C sham ultrasound for massage - 5 minutes

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain severity measured by Numerical Rating Scales (NRS)

    zero , no pain .10 maximum pain

    Measured: before intervention and two days after last session

Secondary outcomes (1)
  1. knee functional abilities measured by Western Ontario McMaster Universities Osteoarthritis Index (WOMAC)

    Zero - no functional impairments.96 ,maximum impairments

    Measured: before intervention and two dayes after last sesssion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2025
  2. Study start1 Oct 2022
  3. Primary completion1 Mar 2024
  4. Study completion1 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
randomization
Masking
Single blind
Who is masked
Participant
Enrolment
45 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06798428
Sponsor's protocol ID
HAH00014
Status last verified
Jan 2025
First submitted
11 Jan 2025
Last updated
29 Jan 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing group A will receive ultrasound phonophoresis (Glucosamine, Chondroitin and Some Herbs Extract ) and Group B will receive ultrasound with topical gel , same parameter as group A in people with Grade I and II Knee Meniscal Injuries, run by Eslam Elsayed Ali Shohda at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain severity measured by Numerical Rating Scales (NRS) (time frame: before intervention and two days after last session). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in